Human endothelial cell interaction with biomimetic surfactant polymers containing Peptide ligands from the heparin binding domain of fibronectin
about
Biocompatible and bioactive surface modifications for prolonged in vivo efficacyDialysis and nanotechnology: now, 10 years, or never?Cell-seeding techniques in vascular tissue engineeringQHREDGS enhances tube formation, metabolism and survival of endothelial cells in collagen-chitosan hydrogels.Introduction. Bioengineering the heart.Form Follows Function: Advances in Trilayered Structure Replication for Aortic Heart Valve Tissue Engineering.The influence of RGD-bearing hydrogels on the re-expression of contractile vascular smooth muscle cell phenotype.Two-stage implantation of the skin- and bone-integrated pylon seeded with autologous fibroblasts induced into osteoblast differentiation for direct skeletal attachment of limb prosthesesReview paper: critical issues in tissue engineering: biomaterials, cell sources, angiogenesis, and drug delivery systems.Implants in bone: part I. A current overview about tissue response, surface modifications and future perspectives.Endothelialization of implanted cardiovascular biomaterial surfaces: the development from in vitro to in vivo.Advantages of RGD peptides for directing cell association with biomaterials.Molecular engineering of supramolecular scaffold coatings that can reduce static platelet adhesion.Acute Swine Model for Assessing Biocompatibility of Biomedical Interface Materials.Vascular Tissue Engineering: Progress, Challenges, and Clinical Promise.
P2860
Q26823128-AAE05D18-1866-41DE-9AF0-87C7E552F5E2Q28279057-0BE852D8-B324-4972-900E-447102AEE9FCQ34160631-A332D893-D0B3-4EE6-B638-73CB3DD7D116Q34980989-6B024B93-910F-469D-BC20-BF0CA62D8B15Q36093418-D7FD5B39-E4DC-4D53-AD60-181B5A50327CQ36555578-40834F0B-486C-4D88-93C2-4B558483D641Q37328039-35471A9E-A547-4F4B-9BAA-2D8F29CDED4EQ37672610-C9068A43-D40E-4705-9836-D380CE90ACECQ37934234-B62BD0F8-0C97-47E3-9370-95FFEF43115CQ38084120-814D1811-8FAA-4E11-99B3-5057A20D096AQ38163509-25D09E18-D977-49CF-ACED-7FACBAE6652FQ41884886-5CEC548D-6345-439B-A5FA-0510D31FE3B5Q42532134-7258E602-5C93-4742-95A3-A8064FFF8B61Q47601177-0E560413-406B-4DEC-B015-892637232C32Q52677026-0D1781BD-99AE-42B4-B9F1-E51F1C1CF44E
P2860
Human endothelial cell interaction with biomimetic surfactant polymers containing Peptide ligands from the heparin binding domain of fibronectin
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Human endothelial cell interac ...... binding domain of fibronectin
@ast
Human endothelial cell interac ...... binding domain of fibronectin
@en
Human endothelial cell interac ...... binding domain of fibronectin
@nl
type
label
Human endothelial cell interac ...... binding domain of fibronectin
@ast
Human endothelial cell interac ...... binding domain of fibronectin
@en
Human endothelial cell interac ...... binding domain of fibronectin
@nl
prefLabel
Human endothelial cell interac ...... binding domain of fibronectin
@ast
Human endothelial cell interac ...... binding domain of fibronectin
@en
Human endothelial cell interac ...... binding domain of fibronectin
@nl
P2093
P2860
P356
P1433
P1476
Human endothelial cell interac ...... binding domain of fibronectin
@en
P2093
Eric Anderson
Naomi Sanabria
Roger E Marchant
Sharon Sagnella
P2860
P304
P356
10.1089/TEN.2005.11.226
P577
2005-01-01T00:00:00Z